Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | PRKDC | P78527 | 2/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.35 |
| ▸ | PSD | A5PKW4 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24225922 | 0.92 | ALOX5 (0.36) | ALOX5CYP1A1CYP1B1PRKDCHCRTR1 | |
| SCHEMBL17944549 | 0.91 | ALOX5 (0.44) | ALOX5CYP1A1CYP1B1PRKDCHCRTR1 | |
| SCHEMBL17944166 | 0.91 | ALOX5 (0.43) | ALOX5CYP1A1CYP1B1PRKDCPIM1 | |
| SCHEMBL20131279 | 0.89 | ALOX5 (0.37) | ALOX5CYP1A1CYP1B1PRKDCHCRTR1 | |
| SCHEMBL17932175 | 0.88 | HCRTR1 (0.40) | ALOX5CYP1A1CYP1B1PRKDCHCRTR1 | |
| SCHEMBL23351293 | 0.88 | HCRTR1 (0.40) | ALOX5CYP1A1CYP1B1HCRTR1PSD | |
| SCHEMBL22903279 | 0.88 | HCRTR1 (0.41) | ALOX5CYP1A1CYP1B1PRKDCHCRTR1 | |
| SCHEMBL20127669 | 0.88 | CYP1A1 (0.40) | ALOX5CYP1A1CYP1B1HCRTR1ALDH1A1 | |
| SCHEMBL19081671 | 0.87 | ALOX5 (0.41) | ALOX5CYP1A1CYP1B1PRKDCALDH1A1 | |
| SCHEMBL17944092 | 0.87 | CYP1A1 (0.44) | ALOX5CYP1A1CYP1B1PRKDCPSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220135601-A1 | HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220135601-A1 | HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | CRY1, CYP1A1, CYP1B1 | ALOX5 985/4885CYP1A1 2/4885CYP1B1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.